In addition, in three cases we detected a PIK3CA mutation in plasma DNA which was not present in the corresponding metastatic tissue sample, indicating that ctDNA may further provide insight into tumor heterogeneity and thus avoid tumor sampling bias [46]. The gene discussed is PIK3CA; the disease is neoplasm.